BBSRC Portfolio Analyser
Award details
Elimination of packaging sequences from retroviruses to produce improved vectors for gene delivery
Reference
BB/L024357/1
Principal Investigator / Supervisor
Dr Steven Howe
Co-Investigators /
Co-Supervisors
Institution
University College London
Department
Institute of Child Health
Funding type
Research
Value (£)
143,294
Status
Completed
Type
Research Grant
Start date
01/06/2014
End date
31/05/2015
Duration
12 months
Abstract
unavailable
Summary
The ability to insert genes into cells can be used to study the roles of genes, produce useful proteins like antibodies and correct mutated cells in patients with genetic disorders. Viruses can act as gene delivery vehicles (or 'vectors') because they have evolved the ability to insert genes into cells. We use a modified HIV virus which is unable to reproduce or cause disease but can deliver genes to cells. This vector is used in laboratories across the world but has some drawbacks such as carrying about 18% of the HIV genome and being limited in terms of the size of gene it can deliver. We have already developed a streamlined HIV vector called LTR1 which carries only 3% of the HIV genome. We believe that LTR1 may be an improvement on the previous HIV vector in terms of safety and efficiency so would like to test them side by side. We will licence LTR1 commercially so that this technological breakthrough will be available to as many researchers and industrial partners as possible.
Committee
Not funded via Committee
Research Topics
Microbiology
Research Priority
X – Research Priority information not available
Research Initiative
Follow-On Fund (FOF) [2004-2015]
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search